After initial positive results, a larger international study with the potential drug has now been published in the journal Jama. The principle: The active ingredients are short artificial RNA sequences that specifically block the body’s production of the protein that is responsible for increasing blood pressure. The results show that blood pressure was reduced for several months after the injection was administered. Before approval, the drug must undergo further clinical studies.
Related posts:
Hristo Ivanov: Because of the president's decision not to give the third mandate to DB, we are going...
Xi Jinping Emphasizes Governance and Consensus Building at CPPCC Meeting: Promoting Chinese-style Mo...
Volleyball: European Championship, Italy beats Holland in the tiebreak and is in the semi-final with...
Join the Top Law Firm in Germany - Gleiss Lutz - Seeking Trainees and Research Assistants for China ...